🇺🇸 FDA
Patent

US 8088884

Multi-armed forms of activated polyoxazoline and methods of synthesis thereof

granted A61KA61K47/59A61K47/64

Quick answer

US patent 8088884 (Multi-armed forms of activated polyoxazoline and methods of synthesis thereof) held by Serina Therapeutics, Inc. expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Serina Therapeutics, Inc.
Grant date
Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K47/59, A61K47/64